Drug

413 papers198 directions
Drug is a research venue focused on the intersection of pharmacology, drug development, and computational modeling. With a publication history spanning from 1973 to the present, the venue hosts a corpus of over 400 papers. Its scope encompasses a wide range of topics, including structure-based drug design, nanoscale delivery systems, and the evaluation of natural products. Research often centers on bridging the gap between in vitro models and in vivo applications, as well as addressing the preclinical translational gap in therapeutic development. In the context of machine learning and artificial intelligence, the venue publishes work on advanced computational representations for molecular geometry. This includes research into 3D geometric representations for molecular neural networks and Euclidean equivariant representations. These methods are applied to tasks such as modeling protein flexibility and decoding complex medicines through molecular docking and network pharmacology. Additionally, the venue features the application of natural language processing to clinical data, such as emergency department records for opioid poisoning surveillance. The venue also serves as a platform for clinical and pharmacokinetic research. It includes studies on dose proportionality in early-phase development, comparative pharmacokinetics, and Phase I dose-escalation trials. Notable research directions involve the study of cytochrome P450 splice variants and the development of next-generation drug conjugates for conditions like breast cancer. Prolific contributors to the venue include researchers such as Elizabeth Stuart, Yu Chen, and Dan Li, who contribute to its focus on both the mechanistic and translational aspects of pharmaceutical science.

Papers by Year

2026 5
2025 37
2024 35
2023 32
2022 30
2021 17
2020 23
2019 16
2018 21
2017 20
2016 15
2015 17
2014 21
2013 7
2012 6
2011 11
2010 12
2009 7
2008 14
2007 9
2006 4
2005 4
2004 3
2003 6
2002 6
2001 2
2000 2
1999 3
1998 1
1997 1
1996 3
1995 3
1994 2
1993 4
1992 4
1990 2
1989 1
1980 1
1975 3
1973 3

Top Research Directions

Research directions most represented by papers from this venue.

Microenvironment Triggered Cargo Release from Smart Nanocarriers 7
Overcoming Bioavailability Barriers for Poorly Soluble Compounds 6
Flattening the Pharmacokinetic Curve via Sustained Release Depots 4
Overcoming the Pharmacokinetic Characterization Gap 4
Predicting Ligand Protein Binding via Molecular Docking 4
Bridging the Cross Species Clinical Translation Gap 4
Ligand Mediated Active Targeting of Nanocarriers 3
Engineering Precision Vehicles for Targeted RNA Delivery 3
Closed-Loop Behavioral Nudging Through Real-Time Sensing 2
Scaling Chemical and Phenotypic Screens for Drug Discovery 2
Biogenic Synthesis of Biocompatible Functional Nanomaterials 2
Mechanisms of Metabolic Drug-Drug Interactions 2
Engineering Nanoparticle Size for Passive Tissue Targeting 2
The Preclinical Toxicity Assessment Gap 2
Competitive Interception of Viral Host Interactions 2

Top Authors

AuthorPapers
Elizabeth Stuart16
Shikhar Shrestha6
James R. Brown5
Lars Olsen4
W. Alex Mason4
Benjamin M. Marlin3
George Hripcsak3
Bilal Khan2
Bing He2
Günter Klambauer2
Jiang Bian2
Michael Habeck2
Sepp Hochreiter2
Thierry Langer2
Thomas Seidel2
Wei Wei2
Alan Aspuru-Guzik1
Alexander Baras1
Alfio Ferrara1
Ali Hojjat1

Impactful Papers

Papers from this venue that shaped research clusters.

Foundational

Influential

Related Venues

Venues with the most similar research cluster distributions.

Papers

TitleYear
Time-varying effects of smoking quantity and nicotine dependence on adolescent smoking regularity2012
Using dopamine research to generate rational cannabinoid drug policy2012
A network-based approach to quantifying the impact of biologically active substances2011
Computational biology approaches for selecting host–pathogen drug targets2011
Computational models for predicting substrates or inhibitors of P-glycoprotein2011
Computer-based Evolutionary Search for a Nonlinear Conversion Function for Establishing In Vitro-In Vivo Correlation (IVIVC) of Oral Drug Formulations2011
Efficacy and safety of gonadotropin-releasing hormone agonists used in the treatment of prostate cancer2011
Electrostatic droplets assisted synthesis of alginate microcapsules2011
Ethnic-specific meta-analyses of association between the OPRM1 A118G polymorphism and alcohol dependence among Asians and Caucasians2011
Prevalence and factors associated with off-label antidepressant prescriptions for insomnia2011
Rifampin, but not rifabutin, may produce opiate withdrawal in buprenorphine-maintained patients2011
Systems chemical biology and the Semantic Web: what they mean for the future of drug discovery research2011
The effect of two elementary school-based prevention interventions on being offered tobacco and the transition to smoking2011
Computational Prediction of Binding Affinity for CYP1A2-Ligand Complexes Using Empirical Free Energy Calculations2010
Does heavy adolescent marijuana use lead to criminal involvement in adulthood? Evidence from a multiwave longitudinal study of urban African Americans2010
Estimating the risk of fatal arrhythmia in patients in methadone maintenance treatment for heroin addiction2010
Functionalized carbon nanotubes for potential medicinal applications2010
In silico structure‐activity‐relationship (SAR) models from machine learning: a review2010
In Vitro Metabolism, Permeability, and Efflux of Bazedoxifene in Humans2010
Macroautophagy modulates cellular response to proteasome inhibitors in cancer therapy2010
Pharmacokinetic and Pharmacodynamic Properties of Cholinesterase Inhibitors Donepezil, Tacrine, and Galantamine in Aged and Young Lister Hooded Rats2010
Protein Phosphatase 2Cβl Regulates Human Pregnane X Receptor-Mediated CYP3A4 Gene Expression in HepG2 Liver Carcinoma Cells2010
Repeated-dose (28 days) oral toxicity study in rats of an antiacne formula (BC-AF) derived from plants2010
Strategies for 3D pharmacophore-based virtual screening2010
マウス由来樹状細胞(JAWS-II)における高ルシフェラーゼ活性を呈するKALA修飾T-MENDベクターによるMHCクラス1介在の抗原提示2010
An error analysis of probabilistic fibre tracking methods: average curves optimization2009
Chemical stability of 4′-azidocytidine and its prodrug balapiravir2009
Comparing overdose mortality associated with methadone and buprenorphine treatment2009
Computational analysis of membrane proteins: the largest class of drug targets2009
Fenofibrate Metabolism in the Cynomolgus Monkey using Ultraperformance Liquid Chromatography-Quadrupole Time-of-Flight Mass Spectrometry-Based Metabolomics2009
High Quality 3 Pin XLR Audio Cable Male to Female Microphone for Mixer Amplifier2009
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone2009
Absorption, Metabolism, and Excretion of [14C]Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in Humans2008
A Survey of cDNA Microarray Normalization and a Comparison by k-NN Classification2008
Classification of Cytochrome P450 1A2 Inhibitors and Noninhibitors by Machine Learning Techniques2008
Current Statistical Requirements for Pharmaceutical Clinical Trials in China2008
Data Mining in Pharmacovigilance Practice: Which Algorithm to Use?2008
Depressed mood and the effect of two universal first grade preventive interventions on survival to the first tobacco cigarette smoked among urban youth2008
Disposition of Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in Rats and Dogs2008
Hydroxyitraconazole, Formed During Intestinal First-Pass Metabolism of Itraconazole, Controls the Time Course of Hepatic CYP3A Inhibition and the Bioavailability of Itraconazole in Rats2008
Impacts of age of onset of substance use disorders on risk of adult incarceration among disadvantaged urban youth: A propensity score matching approach2008
Metabolic Profiling and Cytochrome P450 Reaction Phenotyping of Medroxyprogesterone Acetate2008
Optimising the benefits of unobserved dose administration for stable opioid maintenance patients: Follow-up of a randomised trial2008
PharmGKB: Understanding the Effects of Individual Genetic Variants2008
The interaction of conduct problems and depressed mood in relation to adolescent substance involvement and peer substance use2008
UDP-Glucuronosyltransferase 1A6 Is the Major Isozyme Responsible for Protocatechuic Aldehyde Glucuronidation in Human Liver Microsomes2008
Application of Pharmacogenomics in Drug Discovery and Development:Correlations Between Transcriptional Modulation and Preclinical Safety Observations2007
Breast Cancer Resistance Protein 1 Limits Fetal Distribution of Nitrofurantoin in the Pregnant Mouse2007
Constructing evidence-based treatment strategies using methods from computer science2007
Customizing treatment to the patient: Adaptive treatment strategies2007

« prev Page 7/9 next »